Envía por correo este artículo 
Prevalencia de enfermedades cardiovasculares en personas que han sufrido COVID-19: miocarditis, insuficiencia cardiaca y otros traumas
Resumen
Palabras clave
Referencias
Vosko I, Zirlik A, Bugger H. Impact of COVID-19 on Cardiovascular Disease. Viruses. 11 de febrero de 2023;15(2):508.
World Health Organization. COVID-19 significantly impacts health services for noncommunicable diseases [Internet]. 2020 [citado 9 de febrero de 2025]. Disponible en: https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases
OPS. Las enfermedades del corazón siguen siendo la principal causa de muerte en las Américas - OPS/OMS | Organización Panamericana de la Salud [Internet]. 2021 [citado 9 de febrero de 2025]. Disponible en: https://www.paho.org/es/noticias/29-9-2021-enfermedades-corazon-siguen-siendo-principal-causa-muerte-americas
Hilser JR, Spencer NJ, Afshari K, Gilliland FD, Hu H, Deb A, et al. COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type. Arteriosclerosis, Thrombosis, and Vascular Biology. noviembre de 2024;44(11):2321-33.
Goroei E, Raesi R, Pooladvand V, Ardaneh M, Daneshi S, Abolfazl S, et al. Investigating the Impact of COVID-19 on the Incidence of Cardiovascular Diseases: A Cross-sectional Study. [citado 8 de enero de 2025]; Disponible en: https://openpublichealthjournal.com/VOLUME/17/ELOCATOR/e18749445311093/FULLTEXT/
Speranza M, López-López JD, Schwartzmann P, Morr I, Rodríguez-González MJ, Buitrago A, et al. Cardiovascular Complications in Patients with Heart Failure and COVID-19: CARDIO COVID 19-20 Registry. J Cardiovasc Dev Dis. 23 de enero de 2024;11(2):34.
Rivadeneira J, Fuenmayor-González L, Jácome-García M, Flores-Lastra N, Delgado H, Otzen T. Impact of COVID-19 on the prevalence of dyslipidemia in Ecuador: A cross-sectional study between 2017 and 2022. Atención Primaria. 1 de abril de 2025;57(4):103007.
Apolinario Alava AI. Complicaciones por COVID-19 en adultos de 20 a 64 años en un hospital municipal, Guayaquil – Ecuador 2020 - 2021. Repositorio Institucional - UCV [Internet]. 2023 [citado 21 de junio de 2024]; Disponible en: https://repositorio.ucv.edu.pe/handle/20.500.12692/115220
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas. Revista Española de Cardiología. 1 de septiembre de 2021;74(9):790-9.
Zhang B, Thacker D, Zhou T, Zhang D, Lei Y, Chen J, et al. Post-Acute Cardiovascular Outcomes of COVID-19 in Children and Adolescents: An EHR Cohort Study from the RECOVER Project. medRxiv. 15 de mayo de 2024;2024.05.14.24307380.
Bavishi A, Kliethermes SA, Petek B, Moulson N, Mellacheruvu P, Churchill TW, et al. Clinical spectrum of COVID-19 complications in young adults: combined analysis of the American Heart Association COVID-19 Cardiovascular Disease Registry and the Outcomes Registry for Cardiac Conditions in Athletes. BMJ Open. 12 de abril de 2023;13(4):e069943.
Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR, et al. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. JAMA. 25 de enero de 2022;327(4):331-40.
Fedeli U, Saia M, Carturan E, Pilichou K, Corrado D, Thiene G, et al. Rate and Cause of Sudden Cardiac Death in the Young During the COVID-19 Pandemic and Vaccination. Circulation. 19 de diciembre de 2023;148(25):2069-71.
Trimaille A, Ribeyrolles S, Fauvel C, Chaumont C, Weizman O, Pommier T, et al. Cardiovascular Characteristics and Outcomes of Young Patients with COVID-19. J Cardiovasc Dev Dis. 26 de noviembre de 2021;8(12):165.
Vosko I, Zirlik A, Bugger H. Impact of COVID-19 on Cardiovascular Disease. Viruses. 11 de febrero de 2023;15(2):508.
Faghy MA, Yates J, Hills AP, Jayasinghe S, da Luz Goulart C, Arena R, et al. Cardiovascular disease prevention and management in the COVID-19 era and beyond: An international perspective. Prog Cardiovasc Dis. 2023;76:102-11.
Battistoni A, Volpe M, Morisco C, Piccinocchi G, Piccinocchi R, Fini M, et al. Persistent increase of cardiovascular and cerebrovascular events in COVID-19 patients: a 3-year population-based analysis. Cardiovasc Res. 7 de mayo de 2024;120(6):623-9.
Rodriguez-Gonzalez M, Castellano-Martinez A, Cascales-Poyatos HM, Perez-Reviriego AA. Cardiovascular impact of COVID-19 with a focus on children: A systematic review. World J Clin Cases. 6 de noviembre de 2020;8(21):5250-83.
Koyama AK, Imperatore G, Rolka DB, Lundeen E, Rutkowski RE, Jackson SL, et al. Risk of Cardiovascular Disease After COVID-19 Diagnosis Among Adults With and Without Diabetes. J Am Heart Assoc. 4 de julio de 2023;12(13):e029696.
Rodriguez PJ, Goodwin Cartwright BM, Gratzl S, Brar R, Baker C, Gluckman TJ, et al. Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity. JAMA Internal Medicine. 1 de septiembre de 2024;184(9):1056-64.
Ishigami J, Kou M, Ding N, Matsushita K. Cardiovascular Disease and Coronavirus Disease 2019: Epidemiology, Management, and Prevention. Curr Epidemiol Rep. 2021;8(1):1-8.
Quindry JC, Xi L. Impact of COVID-19 pandemic on cardiovascular health in sedentary and athletes: Consensus, uncertainties, and ways for mitigation. Sports Medicine and Health Science. 6 de junio de 2024;6(3):205.
Sahni S, Gupta G, Sarda R, Pandey S, Pandey RM, Sinha S. Impact of metabolic and cardiovascular disease on COVID-19 mortality: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome. 6 de octubre de 2021;15(6):102308.
Flaherty GT, Hession P, Liew CH, Lim BCW, Leong TK, Lim V, et al. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations. Tropical Diseases, Travel Medicine and Vaccines. 28 de agosto de 2020;6(1):16.
Song S, Guo C, Wu R, Zhao H, Li Q, Dou JH, et al. Impact of the COVID-19 pandemic on cardiovascular mortality and contrast analysis within subgroups. Front Cardiovasc Med. 2024;11:1279890.
Sha’ari NI, Ismail A, Abdul Aziz AF, Suddin LS, Azzeri A, Sk Abd Razak R, et al. Cardiovascular diseases as risk factors of post-COVID syndrome: a systematic review. BMC Public Health. 10 de julio de 2024;24(1):1846.
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. mayo de 2020;17(5):259-60.
Sun M, Yuan M, Lai H, Wang Q, Wang H, Xing L, et al. Increased risk of new-onset cardiovascular disease after COVID-19: A systematic review and meta-analysis of 14 cohorts. Reviews in Medical Virology. 2024;34(2):e2518.
Padilla-Rivas GR, Delgado-Gallegos JL, Garza-Treviño G, Galan-Huerta KA, G-Buentello Z, Roacho-Pérez JA, et al. Association between mortality and cardiovascular diseases in the vulnerable Mexican population: A cross-sectional retrospective study of the COVID-19 pandemic. Front Public Health. 10 de noviembre de 2022;10:1008565.
Gómez-Mesa JE, Galindo-Coral S, Montes MC, Alarco W, Barisani JL, Magaña A, et al. Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry. Glob Heart. 16(1):14.
Paulino MR, Moreira JA de S, Correia MG, dos Santos LRA, Duarte IP, Sabioni LR, et al. COVID-19 in patients with cardiac disease: Impact and variables associated with mortality in a cardiology center in Brazil. Am Heart J Plus. 20 de noviembre de 2021;12:100069.
de Diego-Castell MC, García-López E, Álvarez-Gregori JA, Mohedano-Moriano A, Criado-Álvarez JJ, González-González J. [Cardiovascular disease before and after COVID-19 infection: One-year survival]. Semergen. 2024;50(1):102090.
Warren C, Davidson JA, Strongman H, Herrett E, Smeeth L, Breuer J, et al. Severe COVID-19 outcomes by cardiovascular risk profile in England in 2020: a population-based cohort study. Lancet Reg Health Eur. 7 de marzo de 2023;27:100604.
Gallego P, Ruperti-Repilado FJ, Schwerzmann M. Adults with congenital heart disease during the coronavirus disease 2019 (COVID-19) pandemic: are they at risk? Rev Esp Cardiol (Engl Ed). octubre de 2020;73(10):795-8.
Whittaker H, Kallis C, Bolton T, Wood A, Walker S, Sheikh A, et al. Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease. Int J Epidemiol. 11 de abril de 2024;53(3):dyae068.
Khan Y, Verhaeghe N, Devleesschauwer B, Cavillot L, Gadeyne S, Pauwels NS, et al. Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review. Lancet. noviembre de 2023;402 Suppl 1:S61.
Livingston G, Huntley J, Liu KY, Costafreda SG, Selbæk G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 10 de agosto de 2024;404(10452):572-628.
Sabatino J, Di Salvo G, Calcaterra G, Bassareo PP, Oreto L, Cazzoli I, et al. Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization. International Journal of Cardiology Congenital Heart Disease. agosto de 2021;4:100186.
Krishna BA, Metaxaki M, Sithole N, Landín P, Martín P, Salinas-Botrán A. Cardiovascular disease and covid-19: A systematic review. IJC Heart & Vasculature. 1 de octubre de 2024;54:101482.
Costa R, Castagna A, Ruotolo G. COVID‐19 and cardiovascular problems in elderly patients: Food for thought. Aging Med (Milton). 28 de febrero de 2021;4(2):146-52.
Karadavut S, Altintop I. Long-term cardiovascular adverse events in very elderly COVID-19 patients. Arch Gerontol Geriatr. 2022;100:104628.
Alves M, Fernandes MA, Bahat G, Benetos A, Clemente H, Grodzicki T, et al. Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications. Eur Geriatr Med. 2021;12(4):725-39.
Napoli C, Tritto I, Benincasa G, Mansueto G, Ambrosio G. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review. Ann Med Surg (Lond). 5 de agosto de 2020;57:236-43.
Sindet-Pedersen C, Michalik F, Strange JE, Christensen DM, Nouhravesh N, Gerds TA, et al. Risk of Worsening Heart Failure and All-Cause Mortality Following COVID-19 Vaccination in Patients With Heart Failure: A Nationwide Real-World Safety Study. Circulation: Heart Failure. octubre de 2023;16(10):e010617.
Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron LM, Pagliaro P, et al. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. GeroScience. 20 de mayo de 2020;42(4):1021-49.
Rivera-Torres J, Girón N, San José E. COVID-19: A Comprehensive Review on Cardiovascular Alterations, Immunity, and Therapeutics in Older Adults. J Clin Med. 6 de enero de 2023;12(2):488.
Krishna BA, Metaxaki M, Sithole N, Landín P, Martín P, Salinas-Botrán A. Cardiovascular disease and covid-19: A systematic review. Int J Cardiol Heart Vasc. 2 de agosto de 2024;54:101482.
Xu Y, Li H, Santosa A, Wettermark B, Fall T, Björk J, et al. Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study. Eur Heart J. 7 de enero de 2025;46(2):147-57.
Jan B, Dar MI, Choudhary B, Basist P, Khan R, Alhalmi A. Cardiovascular Diseases Among Indian Older Adults: A Comprehensive Review. Cardiovascular Therapeutics. 2024;2024(1):6894693.
Yun C, Lee Y, Heo SJ, Kim N, Jung I. The impact of COVID-19 status and vaccine type following the first dose on acute heart disease: A nationwide retrospective cohort study in South Korea. Epidemiol Infect. 24 de octubre de 2024;152:e134.
Xu S chi, Zhao X yue, Xing H ping, Wu W, Zhang S yang. Cardiac Involvement in COVID-19: A Global Bibliometric and Visualized Analysis. Front Cardiovasc Med. 27 de julio de 2022;9:955237.
Dayaramani C, De Leon J, Reiss AB. Cardiovascular Disease Complicating COVID-19 in the Elderly. Medicina (Kaunas). 17 de agosto de 2021;57(8):833.
Howick JF, Saric P, Elwazir M, Newman DB, Pellikka PA, Howick AS, et al. A Pragmatic Study of Cardiovascular Disease During Long-Term COVID-19. Am J Med. marzo de 2025;138(3):532-540.e1.
Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. septiembre de 2020;17(9):543-58.
Woodruff RC, Tong X, Khan SS, Shah NS, Jackson SL, Loustalot F, et al. Trends in Cardiovascular Disease Mortality Rates and Excess Deaths, 2010–2022. American Journal of Preventive Medicine. 1 de abril de 2024;66(4):582-9.
Cataneo-Piña DJ, Álvarez-Gutierrez L, Correa-Carrera RP, Domínguez-Rivera DU, Ojeda LAL y. Vulnerabilidad cardiovascular en adultos mayores con COVID-19: conociendo los mecanismos biológicos. Arch Cardiol Mex. 2021;91(Supl):74-8.
Huang L wei, Li H min, He B, Wang X bo, Zhang Q zhi, Peng W xing. Prevalence of cardiovascular symptoms in post-acute COVID-19 syndrome: a meta-analysis. BMC Med. 6 de febrero de 2025;23:70.
Ahmadi A, Sabri MR, Ghaderian M, Dehghan B, Mahdavi C, Mohkamkar N. Cardiovascular Complications in Children Post COVID-19: A Systematic Review. Adv Biomed Res. 28 de octubre de 2024;13:94.
Giustino G, Croft LB, Stefanini GG, Bragato R, Silbiger JJ, Vicenzi M, et al. Characterization of Myocardial Injury in Patients With COVID-19. J Am Coll Cardiol. 3 de noviembre de 2020;76(18):2043-55.
Pellicori P, Doolub G, Wong CM, Lee KS, Mangion K, Ahmad M, et al. COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database Syst Rev. 11 de marzo de 2021;2021(3):CD013879.
Giugni FR, Duarte-Neto AN, da Silva LFF, Monteiro RAA, Mauad T, Saldiva PHN, et al. Younger age is associated with cardiovascular pathological phenotype of severe COVID-19 at autopsy. Front Med (Lausanne). 8 de enero de 2024;10:1327415.
Ziapour A, Lebni JY, Mohammadkhah F, Chaboksavar F, Janjani P, Yıldırım M. Challenging experiences of the elderly with heart failure in the COVID-19 pandemic: a phenomenological study in Iran. BMC Geriatrics. 11 de diciembre de 2023;23(1):834.
Biamonte F, Botta C, Mazzitelli M, Rotundo S, Trecarichi EM, Foti D, et al. Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility. Journal of Translational Medicine. 17 de febrero de 2021;19(1):79.
Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. marzo de 2022;28(3):583-90.
Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 1 de noviembre de 2020;5(11):1265-73.
DOI: https://doi.org/10.23857/pc.v10i3.10239
Enlaces de Referencia
- Por el momento, no existen enlaces de referencia
Polo del Conocimiento
Revista Científico-Académica Multidisciplinaria
ISSN: 2550-682X
Casa Editora del Polo
Manta - Ecuador
Dirección: Ciudadela El Palmar, II Etapa, Manta - Manabí - Ecuador.
Código Postal: 130801
Teléfonos: 056051775/0991871420
Email: polodelconocimientorevista@gmail.com / director@polodelconocimiento.com
URL: https://www.polodelconocimiento.com/
